0.4301
price down icon28.60%   -0.1723
after-market Handel nachbörslich: .42 -0.0101 -2.35%
loading
Schlusskurs vom Vortag:
$0.6024
Offen:
$0.5705
24-Stunden-Volumen:
6.06M
Relative Volume:
0.53
Marktkapitalisierung:
$21.30M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+91.16%
1M Leistung:
-8.49%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$0.4012
$0.5763
1-Wochen-Bereich:
Value
$0.227
$0.7301
52-Wochen-Spanne:
Value
$0.215
$2.10

Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile

Name
Firmenname
Aspire Biopharma Holdings Inc
Name
Telefon
561-704-8527
Name
Adresse
194 CANDELARO DRIVE, #233, HUMACAO
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
ASBP's Discussions on Twitter

Vergleichen Sie ASBP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ASBP
Aspire Biopharma Holdings Inc
0.4301 11.14M 0 0 0 0.00
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten

pulisher
May 29, 2025

Aspire Biopharma provides development update on BUZZ BOMB supplement - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Aspire Biopharma (ASPH) Stock Explodes Over 160%: What's Behind the Monumental Surge? - Daily Chhattisgarh News

May 28, 2025
pulisher
May 28, 2025

Pharma Stock Massively Bid Up Following New Product Announcement - The Globe and Mail

May 28, 2025
pulisher
May 28, 2025

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025 - ACCESS Newswire

May 28, 2025
pulisher
May 21, 2025

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - New Castle News

May 21, 2025
pulisher
May 20, 2025

ASBP stock touches 52-week low at $0.22 amid sharp annual decline - Investing.com India

May 20, 2025
pulisher
May 20, 2025

Sidoti Events, LLC's Virtual May Micro-Cap Conference - FinancialContent

May 20, 2025
pulisher
May 16, 2025

Aspire Biopharma announces resale of up to 11.26M shares - MSN

May 16, 2025
pulisher
May 14, 2025

Aspire Biopharma Holdings, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 08, 2025

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21 - ACCESS Newswire

May 08, 2025
pulisher
May 02, 2025

Aspire Biopharma Holdings Inc (ASBP) Stock: A Comprehensive 52-Week Review - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Was anything negative for Aspire Biopharma Holdings Inc (ASBP) stock last session? - uspostnews.com

May 02, 2025
pulisher
May 02, 2025

Post-Trade Analysis: Aspire Biopharma Holdings Inc (ASBP) Slides -15.33, Closing at 0.36 - DWinneX

May 02, 2025
pulisher
May 01, 2025

Aspire Biopharma Settles with Lenders, Extends Loan Maturities By Investing.com - Investing.com Nigeria

May 01, 2025
pulisher
Apr 30, 2025

Aspire Biopharma Settles with Lenders, Extends Loan Maturities - Investing.com Australia

Apr 30, 2025
pulisher
Apr 29, 2025

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - The Joplin Globe

Apr 29, 2025
pulisher
Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025
pulisher
Apr 28, 2025

Former Nasdaq Private Market President Takes LogicMark's Helm: Inside the AI-Driven Healthcare Tech Transformation - Stock Titan

Apr 28, 2025
pulisher
Apr 26, 2025

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17 - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 24, 2025

ASBPAspire Biopharma Holdings Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 11, 2025

Aspire Biopharma starts production of pre-workout supplement By Investing.com - Investing.com South Africa

Apr 11, 2025
pulisher
Apr 11, 2025

Aspire Biopharma starts production of pre-workout supplement - Investing.com Australia

Apr 11, 2025
pulisher
Apr 11, 2025

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement - standard-journal.com

Apr 11, 2025
pulisher
Apr 09, 2025

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation - Weatherford Democrat

Apr 09, 2025
pulisher
Apr 07, 2025

Aspire Biopharma Holdings Inc. (ASBP) reports earnings - Quartz

Apr 07, 2025
pulisher
Apr 07, 2025

Aspire Biopharma Holdings, Inc. SEC 10-K Report - TradingView

Apr 07, 2025
pulisher
Apr 05, 2025

ASBP stock touches 52-week low at $0.51 amid sharp annual decline - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

ASBP stock touches 52-week low at $0.51 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Mar 21, 2025

There is no way Aspire Biopharma Holdings Inc (ASBP) can keep these numbers up - SETE News

Mar 21, 2025
pulisher
Mar 20, 2025

Sector Update: Health Care - MarketScreener

Mar 20, 2025
pulisher
Mar 20, 2025

Aspire Biopharma Says Glatt Air Produces First Batch of Oral Mucosal Form of Aspirin -March 20, 2025 at 10:11 am EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin - standard-journal.com

Mar 20, 2025
pulisher
Mar 13, 2025

Aspire Biopharma advances patent applications for drug delivery tech By Investing.com - Investing.com Australia

Mar 13, 2025

Finanzdaten der Aspire Biopharma Holdings Inc-Aktie (ASBP)

Es liegen keine Finanzdaten für Aspire Biopharma Holdings Inc (ASBP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
Kapitalisierung:     |  Volumen (24h):